The four-day MEDICA 2024 has come to a successful conclusion!
▊Exhibition Review
During the exhibition, HymonBio’s booth was very lively, from opening to closing. The world’s first Pan-Cancer Screening Test on the PCR was highly praised by medical professionals around the world for its advanced technology and excellent performance. Many international friends expressed optimism and high hopes for the prospects of HymonBio.
This exhibition has significantly enhanced the international reputation of the company, established initial business contacts with many medical companies and distributors around the world, and laid the foundation for overseas sales and market expansion.
See you at the next stop, Medlab Middle East in Dubai!
Post time: Nov-15-2024